AT321923B - Verfahren zur herstellung von neuen imidazotriazinonen - Google Patents

Verfahren zur herstellung von neuen imidazotriazinonen

Info

Publication number
AT321923B
AT321923B AT982372A AT982372A AT321923B AT 321923 B AT321923 B AT 321923B AT 982372 A AT982372 A AT 982372A AT 982372 A AT982372 A AT 982372A AT 321923 B AT321923 B AT 321923B
Authority
AT
Austria
Prior art keywords
imidazotriazinones
producing new
producing
new
new imidazotriazinones
Prior art date
Application number
AT982372A
Other languages
German (de)
English (en)
Inventor
Susan Constance Garside
David Hartley
Lawrence Henry Charles Lunts
Alexander William Oxford
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Application granted granted Critical
Publication of AT321923B publication Critical patent/AT321923B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT982372A 1971-11-19 1972-11-17 Verfahren zur herstellung von neuen imidazotriazinonen AT321923B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (1)

Publication Number Publication Date
AT321923B true AT321923B (de) 1975-04-25

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT982372A AT321923B (de) 1971-11-19 1972-11-17 Verfahren zur herstellung von neuen imidazotriazinonen

Country Status (18)

Country Link
US (1) US3840537A (cs)
JP (1) JPS563873B2 (cs)
AT (1) AT321923B (cs)
AU (1) AU472127B2 (cs)
BE (1) BE791025A (cs)
CA (1) CA990292A (cs)
CH (1) CH594671A5 (cs)
DE (1) DE2255172A1 (cs)
DK (1) DK138691B (cs)
ES (1) ES408736A1 (cs)
FR (1) FR2160407B1 (cs)
GB (1) GB1400999A (cs)
IE (1) IE37046B1 (cs)
IL (1) IL40686A (cs)
NL (1) NL7215646A (cs)
PH (1) PH9669A (cs)
SE (1) SE402915B (cs)
ZA (1) ZA727532B (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (de) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8-(2,6-Dichlorphenyl)-7-(4-chlorphenyl)-5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazin, Verfahren zu dessen Herstellung und dieses enthaltene Arzneimittel
DE2335193A1 (de) * 1973-07-11 1975-01-30 Hoechst Ag Bis-triazinobenzimidazole und ihre herstellung
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
SI1049695T1 (en) * 1997-11-12 2002-06-30 Bayer Aktiengesellschaft 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
BR9913152A (pt) 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
TR200201317T2 (tr) 1999-08-21 2002-11-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Sinerjistik kombinasyon.
CA2449163C (en) * 2001-05-09 2010-07-13 Bayer Healthcare Ag New use of 2-phenyl-substituted imidazotriazinones
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10135815A1 (de) 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US7462614B2 (en) * 2003-04-01 2008-12-09 Smithkline Beecham Corporation Imidazotriazine compounds
EP2308879A1 (en) 2004-04-02 2011-04-13 OSI Pharmaceuticals, Inc. 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
RU2435588C2 (ru) * 2005-09-29 2011-12-10 Байер Шеринг Фарма Акциенгезельшафт Ингибиторы фдэ и их комбинации для лечения урологических расстройств
KR20080078668A (ko) * 2005-11-17 2008-08-27 오에스아이 파마슈티컬스, 인코포레이티드 융합된 바이사이클릭 mTOR 억제자
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
JP2012524119A (ja) 2009-04-20 2012-10-11 オーエスアイ・ファーマシューティカルズ,エルエルシー C−ピラジン−メチルアミンの調製
CN103374002B (zh) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 磷酸二酯酶-5抑制剂
JP2018508555A (ja) * 2015-03-16 2018-03-29 大日本住友製薬株式会社 二環性イミダゾロ誘導体
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (ja) * 2016-05-27 2017-11-30 塩野義製薬株式会社 5-オキソ-1,2,4-トリアジン誘導体およびその医薬組成物

Also Published As

Publication number Publication date
FR2160407A1 (cs) 1973-06-29
JPS4857993A (cs) 1973-08-14
GB1400999A (en) 1975-07-16
AU4819172A (en) 1974-05-16
PH9669A (en) 1976-02-10
US3840537A (en) 1974-10-08
DK138691B (da) 1978-10-16
IE37046L (en) 1973-05-19
DE2255172A1 (de) 1973-05-24
CA990292A (en) 1976-06-01
DK138691C (cs) 1979-03-26
NL7215646A (cs) 1973-05-22
IE37046B1 (en) 1977-04-27
CH594671A5 (cs) 1978-01-13
SE402915B (sv) 1978-07-24
ES408736A1 (es) 1976-03-01
ZA727532B (en) 1973-07-25
BE791025A (fr) 1973-05-07
FR2160407B1 (cs) 1975-10-17
JPS563873B2 (cs) 1981-01-27
IL40686A0 (en) 1972-12-29
AU472127B2 (en) 1976-05-20
IL40686A (en) 1975-12-31

Similar Documents

Publication Publication Date Title
AT321923B (de) Verfahren zur herstellung von neuen imidazotriazinonen
AT339901B (de) Verfahren zur herstellung von neuen tetrazolderivaten
AT323156B (de) Verfahren zur herstellung von neuen 4-substituierten 3-nitropyrazolverbindungen
AT318804B (de) Verfahren zur Herstellung von neuen 3-Methylencephalosporinen
ATA779373A (de) Verfahren zur herstellung von neuen a-phenylindolderivaten
AT308764B (de) Verfahren zur Herstellung von neuen N-Phosphonomethyl-acrylamiden
AT324330B (de) Verfahren zur herstellung von neuen sulfonylverbindungen
AT328078B (de) Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen
AT322549B (de) Verfahren zur herstellung von neuen anilinobenzoxazolen
AT331808B (de) Verfahren zur herstellung von neuen 1-nitrosoharnstoffderivaten
AT327199B (de) Verfahren zur herstellung von neuen nitrochinazolinonen
AT335424B (de) Verfahren zur herstellung von neuen phenyl-benzyl-ketonen
AT313299B (de) Verfahren zur Herstellung von neuen 2-Fluor-5-halogenphenylharnstoffen
AT322104B (de) Verfahren zur herstellung von neuen pyrono-rifamycinen
AT314099B (de) Verfahren zur Herstellung von neuen Cardenoliden
AT325202B (de) Verfahren zur herstellung von neuen halogenphenylthioacetamidocephalosporinderivaten
AT317240B (de) Verfahren zur herstellung von neuen substituierten biguaniden
AT327205B (de) Verfahren zur herstellung von neuen nitrochinazolinonen
AT323903B (de) Verfahren zur herstellung von neuen alfa-l-talomethylosiden
ATA589575A (de) Verfahren zur herstellung von neuen phenyl-benzyl-ketonen
AT323885B (de) Verfahren zur herstellung von neuen 3-formylrifamycinazinen
AT322103B (de) Verfahren zur herstellung von neuen penicillinderivaten
AT329565B (de) Verfahren zur herstellung von neuen chinazolinderivaten
ATA258672A (de) Verfahren zur herstellung von neuen 17alfa-athinylostriolderivaten
ATA851577A (de) Verfahren zur herstellung von neuen cephalos- porinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee